Evidence map›Paper›PMID 41908972›Full record

ReviewFrontiers in parasitology2026

Onchocerciasis overview: pathogenesis, clinical spectrum, and therapeutic challenges of a neglected tropical disease.

Charity N Njeshi, Alan P Robertson, Richard J Martin

Abstract readReview
In one paragraph

Review in Frontiers in parasitology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Charity N NjeshiDepartment of Biomedical Sciences, Iowa State University, Ames, IA, United States.
Alan P RobertsonDepartment of Biomedical Sciences, Iowa State University, Ames, IA, United States.
Richard J MartinDepartment of Biomedical Sciences, Iowa State University, Ames, IA, United States.

Funding

RESISTANCE &MODULATION OF LEVAMISOLE RECEPTOR CHANNELSR01AI047194 · NIAID · IOWA STATE UNIVERSITY · PI MARTIN, RICHARD JOHN · 2001 to 2021
$5.8M
Slo-1K channels, TRP-2 channels, emodepside and diethylcarbamazine in FilariaR01AI155413 · NIAID · IOWA STATE UNIVERSITY · PI Richard John Martin · 2020 to 2026
$2.7M
NIAID NIH HHS R01 AI047194NIAID NIH HHS R01 AI155413
6 · The paper itself

Abstract

Onchocerciasis is still a major health burden in sub-Saharan Africa and Yemen, where many cases occur as control efforts face persistent obstacles, while smaller, well-defined transmission foci remain in Brazil and Venezuela. Caused by the filarial nematode

Indexed as

drug resistancemass drug administrationneglected tropical diseaseonchocerciasispathogenesisvaccine

Identifiers

PMID41908972
PMCPMC13021665

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.